A line chart from the Institute for Government showing Patients told they have cancer or cancer ruled out within four weeks, April 2021 to August 2025. Performance has fluctuated between 60% and 80% across the whole time period, mostly sticking to the national target of 75%. After a dip to 63.6% in early 2022, the share improved gradually, reaching a high of 80.2% in early 25.